692300-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V between IKK classic and Novartis Pharma GmbH for Kesimpta

World Biggest Tenders Source

This tender with title 692300-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V between IKK classic and Novartis Pharma GmbH for Kesimpta has been published on Bidding Source portal dated 22 Oct 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

692300-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V between IKK classic and Novartis Pharma GmbH for Kesimpta

Tender Type :

Contract Award

Reference No. :

692300

Country :

Germany

Publish Date :

22 Oct 2025

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

693034- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-31 - Denosumab Germany 692194- Germany – Pharmaceutical products – Drug discount agreements with accession option Germany 692978- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient golimumab (ATC code according to WHO: L04AB06) Germany 678563- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-28 - Abatacept Germany 680694- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V for medicinal products (open-house procedure) Germany 679895- Germany – Pharmaceutical products – Pharmaceutical discount agreements from 01.12.2025 for various active ingredients within the framework of an open-house procedure Germany 682722- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Rotigotine, ATC N04BC09 Germany 682674- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient diltiazem, ATC C08DB01 Germany 681628- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredients formoterol and beclometasone, ATC R03AK08 Germany 681203- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient bexarotene, ATC L01XF03 Germany

692300-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V between IKK classic and Novartis Pharma GmbH for Kesimpta

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com